47 related articles for article (PubMed ID: 14768525)
1. Alternative Drug Safety in Children with Nonsteroidal Anti-Inflammatory Drug Hypersensitivity.
Aytekin Güvenir F; Turgay Yağmur İ; Dibek Mısırlıoğlu E
Int Arch Allergy Immunol; 2024 May; ():1-7. PubMed ID: 38815557
[TBL] [Abstract][Full Text] [Related]
2. Meloxicam treatment disrupts the regional structure of innate inflammation sites by targeting the pro-inflammatory effects of prostanoids.
Schäufele TJ; Kolbinger A; Friedel J; Gurke R; Geisslinger G; Weigert A; Pierre S; Scholich K
Br J Pharmacol; 2024 Apr; 181(7):1051-1067. PubMed ID: 37823675
[TBL] [Abstract][Full Text] [Related]
3. Reply to: Letter to the Editor from Malik et al.: Acute kidney injury following subcutaneous meloxicam administration.
Krekis A; King JN; D'Arcy-Howard D; Stapleton N; Elliott J; Pelligand L
J Vet Pharmacol Ther; 2024 May; 47(3):237-238. PubMed ID: 38462540
[No Abstract] [Full Text] [Related]
4. Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs.
Traversa G; Bianchi C; Da Cas R; Abraha I; Menniti-Ippolito F; Venegoni M
BMJ; 2003 Jul; 327(7405):18-22. PubMed ID: 12842950
[TBL] [Abstract][Full Text] [Related]
5. A Report on the Use and Safety of Nonsteroidal Anti-inflammatory Drugs among 22,553 Children from Sample Hospitals in Shanghai.
Wang L; Ma R; Du W
Altern Ther Health Med; 2024 Mar; ():. PubMed ID: 38466056
[TBL] [Abstract][Full Text] [Related]
6. Meloxicam-induced capillaritis with positive rechallenge.
Ben Salem C; Chahed F; Sahnoun D; Slim R; Sriha B; Denguezli M
Br J Clin Pharmacol; 2023 Nov; 89(11):3460-3462. PubMed ID: 37653568
[No Abstract] [Full Text] [Related]
7. Suspected Rivaroxaban-Induced Anaphylaxis Secondary to Ingestion of Rivaroxaban and Nimesulide Without Cross-Reactivity to Dabigatran - A Case Report.
Gumbis G; Česnavičiūtė I; Didžiokaitė G; Gegeckienė D; Kvedarienė V
J Asthma Allergy; 2023; 16():1133-1138. PubMed ID: 37841493
[TBL] [Abstract][Full Text] [Related]
8. Nimesulide: A double-edged sword must be banned.
Bin Khalid MM; Nouman M
J Pak Med Assoc; 2023 Dec; 73(12):2511. PubMed ID: 38083948
[No Abstract] [Full Text] [Related]
9. Efficacy of nimesulide versus meloxicam in the control of pain, swelling and trismus following extraction of impacted lower third molar.
De Menezes SA; Cury PR
Int J Oral Maxillofac Surg; 2010 Jun; 39(6):580-4. PubMed ID: 20409689
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal antiinflammatory drugs: a review.
Curry SL; Cogar SM; Cook JL
J Am Anim Hosp Assoc; 2005; 41(5):298-309. PubMed ID: 16141181
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced urticarias.
Mathelier-Fusade P
Clin Rev Allergy Immunol; 2006 Feb; 30(1):19-23. PubMed ID: 16461991
[TBL] [Abstract][Full Text] [Related]
12. Nimesulide and meloxicam are a safe alternative drugs for patients intolerant to nonsteroidal anti-inflammatory drugs.
Senna GE; Passalacqua G; Dama A; Crivellaro M; Schiappoli M; Bonadonna P; Canonica GW
Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):393-6. PubMed ID: 14768525
[TBL] [Abstract][Full Text] [Related]
13. Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib.
Bavbek S; Celik G; Ozer F; Mungan D; Misirligil Z
J Asthma; 2004 Feb; 41(1):67-75. PubMed ID: 15046380
[TBL] [Abstract][Full Text] [Related]
14. Safety of meloxicam in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and angioedema.
Göksel O; Aydin O; Misirligil Z; Demirel YS; Bavbek S
J Dermatol; 2010 Nov; 37(11):973-9. PubMed ID: 21039786
[TBL] [Abstract][Full Text] [Related]
15. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
Senna G; Bilò MB; Antonicelli L; Schiappoli M; Crivellaro MA; Bonadonna P; Dama AR
Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003
[TBL] [Abstract][Full Text] [Related]
16. Nimesulide in the treatment of patients intolerant of aspirin and other NSAIDs.
Senna GE; Passalacqua G; Andri G; Dama AR; Albano M; Fregonese L; Andri L
Drug Saf; 1996 Feb; 14(2):94-103. PubMed ID: 8852524
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
